Skip to search formSkip to main contentSkip to account menu

Maxaquin

Known as: Logiflox, Pharmacia Brand 1 of Lomefloxacin Hydrochloride 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

lomefloxacinlomefloxacin hydrochloride
lomefloxacin Oral Tablet [Maxaquin]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
[Maxaquin in the combined treatment of tuberculosis].
In the context of experimental and clinical pharmacology, the paper provides evidence for that use of Maxaquine, a… 
1999
1999
Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis
1999
1999
[Effectiveness of maxaquin and tarivid in combined therapy of patients with chronic sinusitis].
1998
1998
[Susceptibility of community-acquired pneumonia pathogens to azithromycin].
Two hundred and sixty eight microbial strains were tested for their antibiotic susceptibility. Azithromycin (sumamed) was shown… 
1997
1997
Use of maxaquin in the treatment of progressive pulmonary tuberculosis occurring with standard chemotherapy regimens
To study the efficacy of the fluoroquinolone maxaquin (lomefloxacin), the latter was used in 27 patients with destructive… 
1997
1997
Bactericidal effects of maxaquin on mycobacterium tuberculosis
: Maxaquine is a fluoroquinolone agent that is effective against Mycobacterium tuberculosis (MBT). The drug was tested for… 
1997
1997
[Clinical and laboratory assessment of therapeutic efficacy of maxaquin in treatment of chlamydial conjunctivitis].
Maxaquin (lomefloxacin), a new fluoroquinolone antibiotic, was used in combined therapy of chlamydial conjunctivitis. The results… 
1994
1994
[Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection].
A clinicolaboratory study on the efficacy of lomefloxacin (maxaquin, Searle, USA) was carried out in the treatment of 31 patients… 
1994
1994
[Maxaquin and ciprofloxacin in the treatment of complicated and recurrent urinary infections in adults].
Clinical efficacy of maxaquin versus ciprofloxacin against complicated or/and recurrent urinary infections (62 patients primarily… 
1994
1994
[Use of a new drug, lomefloxacin (maxaquin), from the fluoroquinolone group in the treatment of patients with wound infection].
A clinicolaboratory study on the efficacy of lomefloxacin (maxaquin, Searle, USA) was carried out in the treatment of 31 patients…